172 related articles for article (PubMed ID: 7692155)
1. Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.
Stoleru L; Wijns W; van Eyll C; Bouvy T; Van Nueten L; Pouleur H
J Cardiovasc Pharmacol; 1993 Aug; 22(2):183-90. PubMed ID: 7692155
[TBL] [Abstract][Full Text] [Related]
2. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction.
Rousseau MF; Chapelle F; Van Eyll C; Stoleru L; Hager D; Van Nueten L; Pouleur H
J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension.
Kamp O; Sieswerda GT; Visser CA
Am J Cardiol; 2003 Aug; 92(3):344-8. PubMed ID: 12888152
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of dl-nebivolol and its enantiomers--a comparison with those of atenolol.
Van de Water A; Xhonneux R; Reneman RS; Janssen PA
Eur J Pharmacol; 1988 Oct; 156(1):95-103. PubMed ID: 3208842
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
De Crée J; Cobo C; Geukens H; Verhaegen H
Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
[TBL] [Abstract][Full Text] [Related]
7. Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy.
Wisenbaugh T; Katz I; Davis J; Essop R; Skoularigis J; Middlemost S; Röthlisberger C; Skudicky D; Sareli P
J Am Coll Cardiol; 1993 Apr; 21(5):1094-100. PubMed ID: 8096228
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol: comparison of the effects of dl-nebivolol, d-nebivolol, l-nebivolol, atenolol, and placebo on exercise-induced increases in heart rate and systolic blood pressure.
Van Nueten L; De Crée J
Cardiovasc Drugs Ther; 1998 Sep; 12(4):339-44. PubMed ID: 9825177
[TBL] [Abstract][Full Text] [Related]
9. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of nebivolol and atenolol on transmitral diastolic filling parameters in patients with essential hypertension.
Tuncer M; Guntekin U; Gunes Y; Gumrukcuoglu HA; Eryonucu B
Adv Ther; 2008 Jun; 25(6):619-26. PubMed ID: 18563311
[TBL] [Abstract][Full Text] [Related]
11. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
Nodari S; Metra M; Dei Cas L
Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
[TBL] [Abstract][Full Text] [Related]
12. Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprolol.
Fang Y; Nicol L; Harouki N; Monteil C; Wecker D; Debunne M; Bauer F; Lallemand F; Richard V; Thuillez C; Mulder P
J Mol Cell Cardiol; 2011 Aug; 51(2):168-76. PubMed ID: 21640121
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of nebivolol at rest and on exertion in patients with heart failure.
Brune S; Schmidt T; Tebbe U; Kreuzer H
Angiology; 1990 Sep; 41(9 Pt 1):696-701. PubMed ID: 1977335
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of nebivolol in man.
Van Bortel LM; de Hoon JN; Kool MJ; Wijnen JA; Vertommen CI; Van Nueten LG
Eur J Clin Pharmacol; 1997; 51(5):379-84. PubMed ID: 9049578
[TBL] [Abstract][Full Text] [Related]
15. Effects of nebivolol versus carvedilol on left ventricular function in patients with chronic heart failure and reduced left ventricular systolic function.
Lombardo RM; Reina C; Abrignani MG; Rizzo PA; Braschi A; De Castro S
Am J Cardiovasc Drugs; 2006; 6(4):259-63. PubMed ID: 16913827
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects.
Cheymol G; Woestenborghs R; Snoeck E; Ianucci R; Le Moing JP; Naditch L; Levron JC; Poirier JM
Eur J Clin Pharmacol; 1997; 51(6):493-8. PubMed ID: 9112066
[TBL] [Abstract][Full Text] [Related]
18. Exercise tolerance with nebivolol and atenolol.
Van Bortel LM; van Baak MA
Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats.
Toblli J; Cao G; Rivas C; Munoz M; Giani J; Dominici F; Angerosa M
J Hypertens; 2010 May; 28(5):1007-19. PubMed ID: 20411618
[TBL] [Abstract][Full Text] [Related]
20. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.
Xhonneux R; Wouters L; Reneman RS; Janssen PA
Eur J Pharmacol; 1990 Jun; 181(3):261-5. PubMed ID: 1974517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
